Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine for Recovery in Bodily Trauma
NCT06046859Phase 4Recruiting
- Sponsor
- University of Florida
- Start
- Mar 2024
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fluoxetine in post-traumatic stress disorder (PTSD), major depressive disorder (MDD), sponsored by University of Florida. Started Mar 2024; status: recruiting.
02
Drugs
fluoxetine
03
Conditions
post-traumatic stress disorder (PTSD)major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06046859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06046859.